www.alk.net
  • Your allergy
    • What is allergy
      • House dust mite allergy
      • Pollen allergy
      • Living with allergy
      • Socio-economic impact
    • What is allergic asthma
    • How is allergy diagnosed
    • Treating allergy
  • Our solutions
    • Consumer healthcare
    • Diagnostics
    • Allergy vaccines
      • Production
    • Emergency medicine
  • Our science
    • Scientific focus
    • Science & technology
    • Pipeline
    • Digital innovation
    • Clinical data sharing
    • Collaboration & partnerships
    • Healthcare Professionals
      • Allergy Immunotherapy
      • Reweal
      • Clinical trials
      • Webinars
      • The Henning Lowenstein Research Award
  • Our company
    • Press
    • Our strategy
    • Our leadership
    • Our history
    • Corporate governance
  • Sustainability
  • Investors
    • Overview
    • Financial reporting
      • Risk management
      • Reporting standards
      • Auditors
    • Governance
      • Executive Leadership Team
      • Board of Directors
    • News & Events
      • Company Releases
      • Company releases (DK)
      • Webcasts & presentations
      • Investor calendar
      • Capital Markets Day 2024
    • The Share
      • Dividend history
      • Analyst coverage
      • Analyst estimates
      • Shareholder information
      • Authorizations
    • Contact IR
    • Annual general meeting
      • Annual general meeting (DK)
    • Capital Markets Day 2024
  • Careers
    • Working at ALK
    • Vacant positions
    • Cultural Beliefs
  • Select country
Search

News release

Links: 
Company Releases
Company releases (DK)
Webcasts & presentations
Investor calendar
Capital Markets Day 2024

« Back

Report on Management’s transactions with ALK-Abelló A/S B-shares and associated securities

March 02, 2016

PDF Version

Supporting Materials:
FM_12_16UK_02032016.pdf

Copenhagen, 2016-03-02 09:43 CET (GLOBE NEWSWIRE) --  

ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): Pursuant to section 28(a) of the Danish Securities Trading Act, ALK-Abelló A/S shall report the following transactions, which ALK has received from the persons listed below: 

In accordance with the guidelines for incentive payments to the Board of Management of ALK-Abelló A/S adopted by the annual general meeting, the Board of Directors undertook to grant conditional shares in ALK-Abelló A/S in March 2013. The conditional shares will be available in March 2016, three years following the date of grant, provided that ALK achieves the pre-agreed targets for vesting and that the employment relationship with the ALK Group has not been terminated by the Company on objective grounds or terminated during the three-year period from the date of grant in 2013. 

Delivery of shares has now taken place according to the conditions for the conditional shares in ALK-Abelló A/S granted in March 2013 to Board of Management and key employees. 
 

NameJens Bager
ReasonFormer President and CEO. Comprised by ALKs insider rules about reporting transactions during his resignation period of six months. Conditional shares vesting during the resignation period are part of severance agreement
IssuerALK-Abelló A/S
ISIN codeDK0060027142
TypeShares
TransactionDelivery of shares
Trading date1 March 2016
MarketNASDAQ OMX Copenhagen A/S
Number925
Market valueDKK 917,896

  

NameHenrik Jacobi
ReasonMember of the Board of Management
IssuerALK-Abelló A/S
ISIN codeDK0060027142
TypeShares
TransactionDelivery of shares
Trading date1 March 2016
MarketNASDAQ OMX Copenhagen A/S
Number525
Market valueDKK 520,968

  

NameSøren Daniel Niegel
ReasonMember of the Board of Management
IssuerALK-Abelló A/S
ISIN codeDK0060027142
TypeShares
TransactionDelivery of shares
Trading date1 March 2016
MarketNASDAQ OMX Copenhagen A/S
Number413
Market valueDKK 409,828

  

NameFlemming Pedersen
ReasonMember of the Board of Management
IssuerALK-Abelló A/S
ISIN codeDK0060027142
TypeShares
TransactionDelivery of shares
Trading date1 March 2016
MarketNASDAQ OMX Copenhagen A/S
Number550
Market valueDKK 545,776

  

NameAndreas Slyngborg Holst
ReasonMember of the Board of Directors (employee-elected)
IssuerALK-Abelló A/S
ISIN codeDK0060027142
TypeShares
TransactionDelivery of shares
Trading date1 March 2016
MarketNASDAQ OMX Copenhagen A/S
Number113
Market valueDKK 112,132

  

ALK-Abelló A/S

 

Contact: Steen Riisgaard, Chairman of the Board of Directors, tel. +45 4574 7576

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share

  • English

    English

  • Search

    Search




Select Country Menu

  • Change Country

Quick Links

  • Contact us
  • News
  • Media
  • Vacant jobs
  • Products

ALK Footer Copyright Text

ALK-Abelló A/S ∙ Bøge Allé 6 ∙ DK-2970 Hørsholm ∙ Denmark ∙ CVR no. 63717916 ∙ T +45 45 74 75 76 Legal disclaimer © ALK ∙ All rights reserved